PharmaCielo Ltd. (PCLO.V)
CAD 0.08
(-5.88%)
CAD 0.08
(-5.88%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -12.01 Million CAD | 7.47% |
| 2022 | -10.5 Million CAD | 59.19% |
| 2021 | -24.83 Million CAD | 41.74% |
| 2020 | -41.55 Million CAD | -27.15% |
| 2019 | -33.21 Million CAD | -27455.69% |
| 2018 | -23.76 Million CAD | -642.21% |
| 2017 | -15.98 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.24 Million CAD | -1.36% |
| 2024 Q1 | -1.31 Million CAD | 69.56% |
| 2023 Q4 | -2.44 Million CAD | -30.11% |
| 2023 Q2 | -2.61 Million CAD | 2.44% |
| 2023 FY | - CAD | 7.47% |
| 2023 Q3 | -1.88 Million CAD | 28.03% |
| 2023 Q1 | -2.68 Million CAD | -356.18% |
| 2022 Q2 | -2.26 Million CAD | 11.59% |
| 2022 Q4 | -587.59 Thousand CAD | 86.45% |
| 2022 FY | - CAD | 59.19% |
| 2022 Q1 | -2.56 Million CAD | 25.78% |
| 2022 Q3 | -4.33 Million CAD | -91.39% |
| 2021 Q1 | -6.44 Million CAD | 69.45% |
| 2021 FY | - CAD | 41.74% |
| 2021 Q4 | -3.45 Million CAD | 56.23% |
| 2021 Q3 | -7.89 Million CAD | -24.81% |
| 2021 Q2 | -6.32 Million CAD | 1.96% |
| 2020 Q4 | -21.1 Million CAD | -261.64% |
| 2020 Q3 | -5.83 Million CAD | 19.32% |
| 2020 Q1 | -6.34 Million CAD | 43.37% |
| 2020 Q2 | -7.23 Million CAD | -13.93% |
| 2020 FY | - CAD | -27.15% |
| 2019 Q1 | -7.81 Million CAD | -74138.96% |
| 2019 FY | - CAD | -27455.69% |
| 2019 Q4 | -11.21 Million CAD | -212.37% |
| 2019 Q3 | -3.58 Million CAD | -7.72% |
| 2019 Q2 | -3.33 Million CAD | 57.36% |
| 2018 Q3 | -37.11 Thousand CAD | -34.89% |
| 2018 FY | - CAD | -642.21% |
| 2018 Q1 | -44.08 Thousand CAD | -345.97% |
| 2018 Q2 | -27.51 Thousand CAD | 37.59% |
| 2018 Q4 | -10.52 Thousand CAD | 71.64% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | -9886.00 CAD | 38.14% |
| 2017 Q3 | -15.98 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.68 Million CAD | -348.226% |
| CanadaBis Capital Inc. | 5.67 Million CAD | 311.674% |
| Decibel Cannabis Company Inc. | 5.67 Million CAD | 311.633% |
| Delivra Health Brands Inc. | 2.35 Million CAD | 610.562% |
| Entourage Health Corp. | -21.39 Million CAD | 43.83% |
| Lifeist Wellness Inc. | -12.76 Million CAD | 5.882% |
| Cannara Biotech Inc. | 17.18 Million CAD | 169.928% |
| Medicure Inc. | 1.27 Million CAD | 1044.118% |
| Rubicon Organics Inc. | 1.94 Million CAD | 716.972% |
| BioSyent Inc. | 9.05 Million CAD | 232.691% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | -884.365% |